A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
14 October, 2026
New FET-PET imaging approach helps target radiotherapy for glioblastoma, FIG trial – TROG 18.06 finds
LATEST NEWS: 14 October 2026 Adding a FET-PET brain
26 September, 2026
Trial finds radiation therapy halves risk of brain tumour recurrence after surgery
LATEST NEWS: 26 September 2026 Giving radiotherapy after surgery